Leadiant Biosciences Revenue, Growth & Competitor Profile

DBA SIGMA-TAU PHARMACEUTICALS, INC.

Company Profile & Annual Report for Leadiant Biosciences

Access the complete profile.

Leadiant Biosciences Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	530 Gaither Rd Ste 300 Rockville, MD 20850

Note: Revenues for privately held companies are statistical evaluations.


Leadiant Biosciences's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Leadiant Biosciences's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Leadiant Biosciences is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Leadiant Biosciences Annual Revenue and Growth Rate

Leadiant Biosciences	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Leadiant Biosciences's revenues are gauged from an analysis of company filings.

Leadiant Biosciences's Income Statement (based on Industry Averages)

Leadiant Biosciences P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Leadiant Biosciences is developing and marketing. Leadiant Biosciences doesn't have any recent trademark applications, indicating Leadiant Biosciences is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
CYIHEALTH Providing continuing medical education classes and providing continuing medical education classes featuring information about eye diseases and cystinosis	02/28/2018
CYSTARAN Eye drops and medicated eye drops	07/21/2010
SIGMA-TAU PHARMASOURCE Providing advertising, marketing and promotional services for the pharmaceutical and medical industry	01/08/2010

See all trademarks and details in the Full Report.

Market Share of Leadiant Biosciences's Largest Competitors

A competitive analysis shows these companies are in the same general field as Leadiant Biosciences, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to Leadiant Biosciences. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
LEADIANT BIOSCIENCES	Rockville, MD	100
SENSEI BIO SUBSIDIARY	Rockville, MD	36
HPI	Rockville, MD	26
REYOUNG	Gaithersburg, MD	8
DAEWOONG AMERICA	Rockville, MD	2
PINNACLE ORTHOPEDIC SERVICES	Germantown, MD	0

Future Competition: Leadiant Biosciences's Fastest Growing Competitors

These companies are in the same general field as Leadiant Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)